Demystified . . . Human endogenous retroviruses

Journal of Clinical Pathology - Molecular Pathology

Volumn 56, Issue 1, 2003, Pages 11-18

  Nelson, P N ^a   Carnegie, P R ^b   Martin, J ^a   Davari Ejtehadi, H ^a   Hooley, P ^a   Roden, D ^a   Rowland Jones, S ^c   Warren, P ^a   Astley, J ^a   Murray, P G ^d  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA ANTIGEN; HYBRID PROTEIN; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; VIRUS PROTEIN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BREAST CANCER; CANCER; CHORIOCARCINOMA; DNA SEQUENCE; GERM CELL TUMOR; HUMAN; LONG TERMINAL REPEAT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RHEUMATIC DISEASE; STOP CODON; TERATOCARCINOMA; TESTIS TUMOR; VIRUS CARCINOGENESIS; VIRUS CLASSIFICATION; VIRUS INFECTION; VIRUS RESISTANCE;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; AUTOIMMUNE DISEASES; CODON, NONSENSE; DNA; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, VIRAL; ENDOGENOUS RETROVIRUSES; GENES, VIRAL; GENOME, HUMAN; HUMANS; NEOPLASMS; PEPTIDES; RNA, MESSENGER; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC;

EID: 0037317086     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.56.1.11     Document Type: Review

References (86)

1. Tristem M. Identification and characterisation of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol 2000;74:3715-30.
2. Coffin J. Endogenous retroviruses. In: Weiss R, Teich N, Varmus H, et al, eds. Molecular biology of tumour viruses, 2nd ed. Cold Spring Harbour, USA: Cold Spring Harbour Laboratory Press, 1985:357-404.
3. Leib-Mosch C, Brack-Werner R, Werner T, et al. Endogenous retroviral elements in human DNA. Cancer Res 1990;50(suppl):5636-42.
4. Boller K, Konig H, Sauter M, et al. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 1993;196:349-53.
5. Lower R, Boller K, Hasenmaier B, et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A 1993;90:4480-4.
6. Nelson PN. Retroviruses in rheumatic diseases. Ann Rheum Dis 1995;55:441-2.
7. Nelson PN, Lever AML, Smith S, et al. Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease. Immunol Invest 1999;28:277-89.
8. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
9. Baumforth KRN, Nelson PN, Digby JE, et al. The polymerase chain reaction demystified. Mol Pathol 1998;52:1-10.
10. Lower R, Lower J, Kurth R. Review. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A 1996;93:5177-84.
11. Bernhard W. Electron microscopy of tumour cells and tumour viruses. Cancer Res 1958;18:491-509.
12. Dalton AJ. Further analysis of detailed structure of types B and C particles. J Natl Cancer Inst 1972;48:1098-9.
13. Coffin J. Genetic diversity and evolution of retroviruses. Curr Top Microbiol Immunol 1992;176:143-64.
14. Martin MA, Bryan T, Rasheed S, et al. Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A 1981;78:4892-6.
15. Larsson E, Kato N, Cohen M. Human endogenous proviruses. Curr Top Microbiol Immunol 1989;148:115-32.
16. Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev 1996;9:72-99.
17. Wilkinson DA, Mager DL, Leong JAC. Endogenous human retroviruses. In: Levy JA, ed. The retroviridae, Vol. 3. New York: Plenum Press, 1994;465-535.
18. Franklin GC, Chretien S, Hanson IM, et al. Expression of human sequences related to those of mouse mammary tumor virus. J Virol 1988;62:1203-10.
19. Andersson ML, Lindeskog M, Medstrand P, et al. Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol 1999;80:255-60.
20. Medstrand P, Blomberg J. Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and B retrovirus: differential transcription in normal human tissues. J Virol 1993;67:6778-87.
21. Ono M, Yasunaga T, Miyata T, et al. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol 1986;60:589-98.
22. Dangel AW, Baker BJ, Mendoza AR, et al. Complement component C4 gene intron 9 as a phylogenetic marker for primates: long terminal repeats of the endogenous retrovirus ERV-K(C4) are a molecular clock of evolution. Immunogenetics 1995;42:41-52.
23. Tonjes RR, Lower R, Boller K, et al. HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S261-7.
24. Barbulescu M, Turner G, Seaman MI, et al. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr Biol 1999;9:861-8.
25. Perl A, Rosenblatt JD, Chen ISY, et al. Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res 1989;17:6841-54.
26. Andersson A, Svensson A, Rolny C, et al. Expression of human endogenous retrovirus ERV3 (HERV-R) mRNA in normal and neoplastic tissues. Int J Oncol 1998;12:309-13.
27. Sauter M, Schommer S, Kremmer E, et al. Human endogenous retrovirus K10: expression of gag protein and detection of antibodies in patients with seminomas. J Virol 1995;69:414-21.
28. Löwer R, Löwer J, Tondera-Koch C, et al. A general method for identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells. Virology 1993;192:501-11.
29. Schulte AM, Shoupeng L, Kurtz A, et al. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci U S A 1996;93:14759-64.
30. Bera TK, Tsukamoto T, Panda DK, et al. Defective retrovirus insertion activates c-Ha-ras proto-oncogene in an MNU-induced rat mammary carcinoma. Biochem Biophys Res Commun 1998;248:835-40.
31. Sauter M, Roemer K, Best B, et al. Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumours. Cancer Res 1996;56:4362-5.
32. Larsson E, Andersson G. Beneficial role of human endogenous retroviruses: facts and hypotheses. Scand J Immunol 1998;48:329-38.
33. Lindeskog M, Medstrand P, Blomberg J. Sequence variation of human endogenous retrovirus ERV9-related elements in an env region corresponding to an immunosuppressive peptide: transcription in normal and neoplastic cells. J Virol 1993;67:1122-6.
34. Sahin U, Türeci Ö, Pfreundschuh M. Serological identification of human tumor antigens. Curr Opin Immunol 1997:9:709-16.
35. Keydar I, Ohno T, Nayak R, et al. Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumour virus proteins. Proc Natl Acad Sci U S A 1984;81:4188-92.
36. Patience C, Simpson GR, Colletta AA, et al. Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line. J Virol 1996;70:2654-7.
37. Ono M, Kawakami M, Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol 1987;61:2059-62.
38. Kurtz A, Schulte AM, Wellstein A. Pleiotrophin and midkine in normal development and tumour biology. Crit Rev Oncog 1995;6:151-7.
39. Rhim JS, Yang JH, Lee IH, et al. Oncogene and transgenics correlates of cancer and risk assessments. In: Zarvos C, ed. Oncogenes and human cancers. New York: Plenum Press, 1992:91-109.
40. Sutkowski N, Conrad B, Thorley-Lawson DA, et al. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001;15:579-89.
41. Garry RF, Fermin CD, Darenn JH, et al. Detection of a human intracisternal particle antigenically related to HIV. Science 1990;250:1127-9.
42. Talal N, Dauphinee MJ, Dany M, et al. Detectian of serum antibodies to retroviral proteins in patients with primary Sjören's syndrome (autoimmune exocrinopathy). Arthritis Rheum 1990;33:774-81.
43. Perl A, Colombo E, Agarwal R, et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndrome: correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995;38:1660-71.
44. Ziegler B, Gay RE, Huang G, et al. Immunohistochemical localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis. Am J Pathol 1989;135:1-5.
45. Nelson PN, Lever AML, Bruckner FE, et al. Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross-react with retroviral antigens. Ann Rheum Dis 1994;53:749-54
46. Di Giovine F, Bailly S, Bootman J, et al. Absence of lentiviral and human T cell leukaemia viral sequences in patients with rheumatoid arthritis. Arthritis Rheum 1994;37:349-58.
47. Herrmann M, Kalden JR. PCR and reverse dot hybridisation for the detection of endogenous retroviral transcripts. J Virol Methods 1994;46:333-48.
48. Herrman M, Neidhart M, Gay S, et al. Retrovirus-associated rheumatic syndromes. Curr Opin Rheumatol 1998;10:347-54.
49. Garson JA, Tuke PW, Giraud P, et al. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 1998;351:33.
50. Christensen T, Sorensen P, Dissing P, et al. Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet 1998;352:1033.
51. Blond J, Beseme F, Duret L, et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999;73:1175-85.
52. Kim HS, Takenako O, Crow TJ. Isolation and phylogeny of endogenous retravirus sequences belonging to the HERV-W family primates. J Gen Virol 1999;80:2613-19.
53. Conrad B, Weissmahr RN, Boni J, et al. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997;90:303-13.
54. Katsumata K, Ikeda H, Sato M, et al. Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin Immunol 1999;93:75-80.
55. Murphy VJ, Harrison LC, Rudert WA, et al. Retroviral superantigens and type 1 diabetes mellitus. Cell 1998;95:9-11.
56. Lower R, Tonjes RR, Boller K, et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 1998;95:11-13.
57. Nakagawa K, Harrison LC. The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 1996;152:194-236.
58. Krieg AM, Gourley MF, Perl A. Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 1992;6:2537-44.
59. Wallace BM, Lasker JS. UV light and HIV gene activation. Science 1992;257:1211-12.
60. Krieg AM, Steinberg AD, Khan AS. Increased expression of novel full-length endogenous MCF-related transcript in autoimmune mouse strains. Virology 1988;162:274-6.
61. Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993;178:461-8.
62. Medstrand P, Lindeskog M, Blomberg J. Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol 1992;73:2463-6.
63. Krieg AM, Gourley MF, Klinman DM, et al. Heterogenous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1992;8:1991-8.
64. Steinhuber S, Brack M, Hunsmann G, et al. Distribution of human endogenous retrovirus HERV-K genomes in humans and different primates. Hum Genet 1995;96:188-92.
65. Boyd MT, Bax CMR, Bax BE, et al. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology 1993;196:905-9.
66. Venables PJW, Brookes SM, Griffith D, et al. Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology 1995;211:589-92.
67. Sverdlov ED. Retroviruses and primate evolution. Bioessays 2000;22:161-71.
68. Mi S, Lee X, Li X-P, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000;403:785-9.
69. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
70. Rowland-Jones SL, Dong T, Fowke KR, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102:1758-65.
71. Roden D, Ejtehadi HD, Rowland-Jones S, et al. Use of bioinformatics to highlight antigenic regions of exogenous and endogenous retroviruses. Immunology 2001;104:S112-13.
72. Kaul R, Rowland-Jones SL, Kimani J, et al. Later seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest 2001;107:341-9.
73. Kambhu S, Falldorf P, Lee JS. Endogenous retroviral long terminal repeats within the HLA-DQ locus. Proc Natl Acad Sci U S A 1990;87:4927-31.
74. Badenhoop K, Tonjes RR, Rau H, et al. Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus. Hum Immunol 1996;50:103-10.
75. Seidl C, Donner H, Petershofen E, et al. An endogenous retroviral long terminal repeat at the HLA-DQB1 gene locus confers susceptibility to rheumatoid arthritis. Hum Immunol 1999;60:63-8.
76. Rasmussen HB, Geny C, Deforges L, et al. Expression of endogenous retrovirus in blood mononuclear cells in brain tissue from multiple sclerosis patients. Acta Neurol Scand 1995;169:38-44.
77. Kapitonov VV, Jurka T. The long terminal repeat of an endogenous retrovirus induces alternative splicing and encodes an additional carboxy-terminal sequence in the human leptin receptor. J Mol Evol 1999;48:248-51.
78. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Biol Cell 2001;21:1973-85.
79. Kazazian HH. Mobile elements and disease. Curr Opin Genet Dev 1998;8;343-50.
80. Muhlemann O, Mock-Casagrande CS, Wang J, et al. Precursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol Cell 2001;8:33-43.
81. Gozukara EM, Kahn SG, Metin A, et al. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J Invest Dermatol 2001;117:197-204.
82. Bittorf T, Busfield SJ, Klinken SP, et al. Truncated erythropoietin receptor in a murine erythroleukemia line. Int J Biochem Cell Biol 1996:28:175-81.
83. Howard M, Frizzell RA, Bedwell DM. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 1996;2:467-9.
84. Woodland DL. Immunity and retroviral superantigens in humans. Trends Immunol 2002:23:57-8.
85. Nelson PN. Fossil renegades. New Sci 1999;161:51.
86. Towler EM, Gulnik SV, Bhat TN, et al. Functional characterization of the protease of human endogenous retrovirus K10: can it complement HIV-1 protease? Biochemistry 1998;37:17137-44.